Top Suppliers:I want be here




81371-54-2

81371-54-2 structure
81371-54-2 structure
  • Name: Momordicoside G
  • Chemical Name: (1R,4S,5S,8R,9R,12S,13S,16S)-8-[(2R,4E)-6-Methoxy-6-methyl-4-hepten-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-yl β-D-allopyranoside
  • CAS Number: 81371-54-2
  • Molecular Formula: C37H60O8
  • Molecular Weight: 632.867
  • Catalog: Natural product Moss
  • Create Date: 2017-11-14 17:08:34
  • Modify Date: 2024-01-03 17:37:34
  • Momordicoside G (Momordicacoside G) is an orally active cucurbitane-type triterpene glycoside. Momordicoside G selectively induces apoptosis of M1-like macrophages, without affecting M2-like macrophages. Momordicoside G reduces intracellular ROS levels and promotes autophagy. Momordicoside G also has anticancer activity, inhibiting the growth of cancer cell lines. Momordicoside G stimulates M2-associated lung injury repair and prevents inflammatory lung cancer injury[1].

Name (1R,4S,5S,8R,9R,12S,13S,16S)-8-[(2R,4E)-6-Methoxy-6-methyl-4-hepten-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-yl β-D-allopyranoside
Synonyms (1R,4S,5S,8R,9R,12S,13S,16S)-8-[(2R,4E)-6-Methoxy-6-methyl-4-hepten-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.0.0.0]nonadec-2-en-16-yl β-D-allopyranoside
momordicoside G
β-D-Allopyranoside, (3S,5R,8S,9S,10S,13R,14S,17R)-1,3,4,8,10,11,12,13,14,15,16,17-dodecahydro-17-[(1R,3E)-5-methoxy-1,5-dimethyl-3-hexen-1-yl]-4,4,13,14-tetramethyl-5,9-(epoxymethano)-2H-cyclopenta [a]phenanthren-3-yl
Momorcharaside A
Description Momordicoside G (Momordicacoside G) is an orally active cucurbitane-type triterpene glycoside. Momordicoside G selectively induces apoptosis of M1-like macrophages, without affecting M2-like macrophages. Momordicoside G reduces intracellular ROS levels and promotes autophagy. Momordicoside G also has anticancer activity, inhibiting the growth of cancer cell lines. Momordicoside G stimulates M2-associated lung injury repair and prevents inflammatory lung cancer injury[1].
Related Catalog
In Vitro 用 10 ng/mL LPS 或 10 ng/mL IL-10 刺激 Raw264.7 巨噬细胞 24 h,获得 M1 样 (iNOS+) 和 M2样 (精氨酸酶+) 巨噬细胞[1]。 Momordicoside G (10-40 μM; 24 h) 抑制 M1 巨噬细胞的细胞活力,对 M2 巨噬细胞无抑制作用。Momordicoside G (40 μM) 体外诱导 M1 巨噬细胞凋亡,降低 NO 水平,增加 IL-12、IL-10 和 TGF-β 水平[1]。 Momordicoside G (40 μM) 可抑制细胞自噬相关标志物 LC3-B 的蛋白水平[1]。 Cell Viability Assay[1] Cell Line: M1 macrophages, M2 macrophages Concentration: 10 μM, 20 μM, 40 μM Incubation Time: 24 hours Result: Selectively decreased the cell viability of M1 macrophages, instead of M2 macrophages.
In Vivo ICR 小鼠的肺部致癌模型由氨基甲酸乙酯 (HY-B1207) (600 mg/kg;腹腔注射;每周一次,持续 4 或 8 周) 诱导,或由 LPS (HY-D1056) (2 mg/kg;气管内施用) 和 4 mg/小鼠 IEC (腹腔注射) 诱导[1]。 Momordicoside G (50 mg/kg;口服;每天一次,持续 4 或 8 周) 在小鼠肺致癌模型中可预防氨基甲酸乙酯引起的肺损伤和癌病变[1]。 Momordicoside G (50 mg/kg;口服;每天一次,持续 2 周) 在 LPS 诱导的肺损伤模型中促进肺损伤修复[1]。 Animal Model: Mouse lung carcinogenic model: Urethane-induced lung carcinogenic model and LPS-induced lung injury model[1] Dosage: 50 mg/kg Administration: Oral gavage; once daily for 4 or 8 weeks Result: Affected inflammasome and cytokines during urethane-induced lung injury and carcinoma lesions. Exhibits macrophage-regulating capacity in LPS-induced lung injury model.
References

[1]. Du Z, et al. Momordicoside G Regulates Macrophage Phenotypes to Stimulate Efficient Repair of Lung Injury and Prevent Urethane-Induced Lung Carcinoma Lesions. Front Pharmacol. 2019 Mar 29;10:321.  

Density 1.2±0.1 g/cm3
Boiling Point 711.4±60.0 °C at 760 mmHg
Molecular Formula C37H60O8
Molecular Weight 632.867
Flash Point 384.0±32.9 °C
Exact Mass 632.428833
PSA 117.84000
LogP 5.40
Vapour Pressure 0.0±5.2 mmHg at 25°C
Index of Refraction 1.574
Hazard Codes Xi
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.